Cargando…

A humanized anti-DLL4 antibody promotes dysfunctional angiogenesis and inhibits breast tumor growth

Blockage of Delta-like 4 (DLL4)-directed Notch signaling induces excessive tip cell formation and endothelial proliferation resulting in dysfunctional angiogenesis in tumors. MMGZ01, as a murine anti-human DLL4 monoclonal antibody, specifically binds to human DLL4 and blocks Notch pathway. Here, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Xuelian, Wang, Wenyi, Xu, Zhuobin, Wang, Shijing, Wang, Tong, Wang, Min, Wu, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908374/ https://www.ncbi.nlm.nih.gov/pubmed/27301650 http://dx.doi.org/10.1038/srep27985

Ejemplares similares

Incomplete Dll4/Notch signaling inhibition promotes functional angiogenesis supporting the growth of skin papillomas
por: Djokovic, Dusan, et al.
Publicado: (2015)

Inhibition of Dll4/Notch1 pathway promotes angiogenesis of Masquelet’s induced membrane in rats
por: Tang, Qian, et al.
Publicado: (2018)

MPDZ promotes DLL4-induced Notch signaling during angiogenesis
por: Tetzlaff, Fabian, et al.
Publicado: (2018)

Low-Dosage Inhibition of Dll4 Signaling Promotes Wound Healing by Inducing Functional Neo-Angiogenesis
por: Trindade, Alexandre, et al.
Publicado: (2012)

Tryptanthrin inhibits tumor angiogenesis via Notch/Dll4 signaling pathway in zebrafish
por: Lin, Meimei, et al.
Publicado: (2023)

Dll4 Blockade Promotes Angiogenesis in Nonhealing Wounds of Sox7-Deficient Mice
por: Yang, Jee Myung, et al.
Publicado: (2020)

Dll4-Notch signaling as a therapeutic target in tumor angiogenesis
por: Kuhnert, Frank, et al.
Publicado: (2011)

Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growth
por: Chen, Xin, et al.
Publicado: (2020)

Analysis of Molecular Mechanism of YiqiChutan Formula Regulating DLL4-Notch Signaling to Inhibit Angiogenesis in Lung Cancer
por: Li, Jiayin, et al.
Publicado: (2021)

The Role of Dll4/Notch Signaling in Normal and Pathological Ocular Angiogenesis: Dll4 Controls Blood Vessel Sprouting and Vessel Remodeling in Normal and Pathological Conditions
por: Lobov, Ivan, et al.
Publicado: (2018)

Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells
por: López-Guerra, Mónica, et al.
Publicado: (2019)

Suppression of human colon tumor by EERAC through regulating Notch/DLL4/Hes pathway inhibiting angiogenesis in vivo
por: Yuan, Chenchen, et al.
Publicado: (2021)

Association of Dll4/Notch and HIF-1a -VEGF Signaling in the Angiogenesis of Missed Abortion
por: Fang, Yan, et al.
Publicado: (2013)

RHOQ is induced by DLL4 and regulates angiogenesis by determining the intracellular route of the Notch intracellular domain
por: Bridges, Esther, et al.
Publicado: (2020)

Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo
por: Geffers, Insa, et al.
Publicado: (2007)

Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo
por: Preuße, Kristina, et al.
Publicado: (2015)

Influence of Dll4 via HIF-1α-VEGF Signaling on the Angiogenesis of Choroidal Neovascularization under Hypoxic Conditions
por: Dong, Xiao, et al.
Publicado: (2011)

Endothelial Dll4 overexpression reduces vascular response and inhibits tumor growth and metastasization in vivo
por: Trindade, Alexandre, et al.
Publicado: (2017)

Xuan Bi Tong Yu Fang Promotes Angiogenesis via VEGF-Notch1/Dll4 Pathway in Myocardial Ischemic Rats
por: Li, Shuangdi, et al.
Publicado: (2020)

The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy?
por: Brzozowa, Marlena, et al.
Publicado: (2013)

Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis
por: Hultgren, Nan W., et al.
Publicado: (2020)

Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53-Dependent VEGFA/Dll4/Notch1 Pathway
por: Zhang, Yongchuan, et al.
Publicado: (2020)

Anti-DLL4, a cancer therapeutic with multiple mechanisms of action
por: Gurney, Austin, et al.
Publicado: (2011)

SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma
por: Liu, Xiao, et al.
Publicado: (2016)

Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody–Drug Conjugate
por: Lashari, Bilal H., et al.
Publicado: (2018)

Dll4 Inhibition Promotes Graft Retention in Fat Grafting Enriched with Adipose-Derived Stem Cells
por: Lee, Choong-kun, et al.
Publicado: (2022)

Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer
por: Silva, Gabriela, et al.
Publicado: (2021)

Fibrinogen‐derived fibrinostatin inhibits tumor growth through anti‐angiogenesis
por: Zhao, Chuanke, et al.
Publicado: (2015)

Distinct expression patterns of Notch ligands, Dll1 and Dll4, in normal and inflamed mice intestine
por: Shimizu, Hiromichi, et al.
Publicado: (2014)

Bone Marrow-Derived Endothelial Progenitors Expressing Delta-Like 4 (Dll4) Regulate Tumor Angiogenesis
por: Real, Carla, et al.
Publicado: (2011)

Blood flow suppresses vascular Notch signalling via dll4 and is required for angiogenesis in response to hypoxic signalling
por: Watson, Oliver, et al.
Publicado: (2013)

Endothelial Jagged1 Antagonizes Dll4/Notch Signaling in Decidual Angiogenesis during Early Mouse Pregnancy
por: Marchetto, Nicole M., et al.
Publicado: (2020)

Fibrotic liver microenvironment promotes Dll4 and SDF-1-dependent T-cell lineage development
por: Gong, Zheng, et al.
Publicado: (2019)

Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer
por: Kumar, Sushil, et al.
Publicado: (2018)

Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis
por: Huang, Qing Bo, et al.
Publicado: (2014)

Dose dependent pharmacokinetics, tissue distribution, and anti-tumor efficacy of a humanized monoclonal antibody against DLL4 in mice
por: Kamath, Amrita V, et al.
Publicado: (2014)

Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations
por: You, Chao, et al.
Publicado: (2013)

Dll4 Blockade Potentiates the Anti-Tumor Effects of VEGF Inhibition in Renal Cell Carcinoma Patient-Derived Xenografts
por: Miles, Kiersten Marie, et al.
Publicado: (2014)

Harnessing DLL3 inhibition: From old promises to new therapeutic horizons
por: Cortinovis, Diego Luigi, et al.
Publicado: (2022)

ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models
por: Yeom, Dong-Hoon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ket34t46f6uf8j50t2qh5re9uv